CA Stock MarketDetailed Quotes

EBM Eastwood Bio-Medical Canada Inc

Watchlist
  • 0.355
  • 0.0000.00%
15min DelayMarket Closed Jul 19 16:00 ET
24.45MMarket Cap-35500P/E (TTM)

Eastwood Bio-Medical Canada Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
288.22%11.47K
88.35%-1.23K
-293.29%-16.89K
123.26%2.63K
54.79%-2.83K
-125.08%-6.09K
4.20%-10.59K
96.31%-4.29K
87.60%-11.28K
-129.79%-6.26K
Net income from continuing operations
26.00%-130.11K
21.66%-54.24K
-264.69%-546.6K
-638.02%-184.23K
-37.49%-117.3K
-500.81%-175.83K
-569.81%-69.23K
75.17%-149.88K
-363.91%-24.96K
51.57%-85.31K
Operating gains losses
----
----
-93.18%84
----
----
----
----
--1.23K
----
----
Depreciation and amortization
-1.22%26.64K
-1.22%26.64K
0.94%107.85K
0.94%26.96K
0.94%26.96K
0.94%26.96K
0.94%26.96K
1.47%106.85K
0.59%26.71K
1.77%26.71K
Other non cashItems
0.00%9.27K
12.07%10.38K
21.66%4.13K
3.02%-23.67K
0.00%9.27K
-0.01%9.27K
0.01%9.27K
128.65%3.4K
38.47%-24.4K
0.01%9.27K
Change In working capital
-20.85%105.68K
-28.68%15.98K
1,124.61%417.64K
1,710.32%183.48K
81.62%78.24K
659.13%133.51K
161.07%22.41K
-91.34%34.1K
113.97%10.14K
-73.35%43.08K
-Change in receivables
143.81%3.85K
-264.13%-23.18K
101.45%124
-86.20%10.34K
35.02%-15.55K
80.75%-8.78K
201.68%14.12K
-333.12%-8.57K
2,590.85%74.88K
-409.19%-23.93K
-Change in prepaid assets
98.71%-200
-48.20%-741
13.49%34.37K
69.63%51.37K
---1K
---15.5K
---500
-18.30%30.28K
--30.28K
--0
-Change in payables and accrued expense
-32.60%104.96K
524.22%101.42K
466.15%41.43K
-149.01%-230.48K
76.43%99.93K
139.82%155.72K
174.87%16.25K
-97.82%7.32K
13.28%-92.56K
-61.94%56.64K
-Change in other working capital
-241.75%-2.93K
-724.87%-61.52K
6,636.17%341.73K
14,401.95%352.26K
-149.57%-5.14K
219.76%2.07K
-573.71%-7.46K
-70.54%5.07K
-1,871.94%-2.46K
104.19%10.37K
Cash from discontinued investing activities
Operating cash flow
288.22%11.47K
88.35%-1.23K
-293.29%-16.89K
123.26%2.63K
54.79%-2.83K
-125.08%-6.09K
4.21%-10.59K
96.31%-4.29K
87.60%-11.28K
-129.79%-6.26K
Investing cash flow
Cash flow from continuing investing activities
0
46.09%-3.01K
Net PPE purchase and sale
----
----
--0
----
----
----
----
46.09%-3.01K
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--0
----
----
----
----
46.09%-3.01K
----
----
Financing cash flow
Cash flow from continuing financing activities
-137.40%-9.3K
36.20%-11.19K
-117.14%-4.5K
-129.33%-4.11K
-163.11%-7.73K
24.88K
-17.54K
31.35%26.27K
14.03K
12.24K
Net issuance payments of debt
-137.40%-9.3K
36.20%-11.19K
-117.14%-4.5K
-129.33%-4.11K
-163.11%-7.73K
--24.88K
---17.54K
31.35%26.27K
--14.03K
--12.24K
Cash from discontinued financing activities
Financing cash flow
-137.40%-9.3K
36.20%-11.19K
-117.14%-4.5K
-129.33%-4.11K
-163.11%-7.73K
--24.88K
---17.54K
31.35%26.27K
--14.03K
--12.24K
Net cash flow
Beginning cash position
-48.55%6.02K
-53.69%18.45K
90.91%39.84K
-50.28%19.94K
-10.61%30.49K
19.32%11.71K
90.91%39.84K
-82.99%20.87K
-65.86%40.1K
-64.64%34.11K
Current changes in cash
-88.47%2.17K
55.84%-12.42K
-212.76%-21.39K
-468.32%-1.49K
-276.27%-10.56K
-22.70%18.78K
-154.44%-28.13K
118.64%18.97K
99.73%-262
-71.48%5.99K
End cash Position
-73.14%8.19K
-48.55%6.02K
-53.69%18.45K
-53.69%18.45K
-50.28%19.94K
-10.61%30.49K
19.32%11.71K
90.91%39.84K
90.91%39.84K
-65.86%40.1K
Free cash from
288.22%11.47K
88.35%-1.23K
-131.37%-16.89K
118.37%2.63K
54.79%-2.83K
-125.08%-6.09K
4.21%-10.59K
94.01%-7.3K
85.21%-14.29K
-129.79%-6.26K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 288.22%11.47K88.35%-1.23K-293.29%-16.89K123.26%2.63K54.79%-2.83K-125.08%-6.09K4.20%-10.59K96.31%-4.29K87.60%-11.28K-129.79%-6.26K
Net income from continuing operations 26.00%-130.11K21.66%-54.24K-264.69%-546.6K-638.02%-184.23K-37.49%-117.3K-500.81%-175.83K-569.81%-69.23K75.17%-149.88K-363.91%-24.96K51.57%-85.31K
Operating gains losses ---------93.18%84------------------1.23K--------
Depreciation and amortization -1.22%26.64K-1.22%26.64K0.94%107.85K0.94%26.96K0.94%26.96K0.94%26.96K0.94%26.96K1.47%106.85K0.59%26.71K1.77%26.71K
Other non cashItems 0.00%9.27K12.07%10.38K21.66%4.13K3.02%-23.67K0.00%9.27K-0.01%9.27K0.01%9.27K128.65%3.4K38.47%-24.4K0.01%9.27K
Change In working capital -20.85%105.68K-28.68%15.98K1,124.61%417.64K1,710.32%183.48K81.62%78.24K659.13%133.51K161.07%22.41K-91.34%34.1K113.97%10.14K-73.35%43.08K
-Change in receivables 143.81%3.85K-264.13%-23.18K101.45%124-86.20%10.34K35.02%-15.55K80.75%-8.78K201.68%14.12K-333.12%-8.57K2,590.85%74.88K-409.19%-23.93K
-Change in prepaid assets 98.71%-200-48.20%-74113.49%34.37K69.63%51.37K---1K---15.5K---500-18.30%30.28K--30.28K--0
-Change in payables and accrued expense -32.60%104.96K524.22%101.42K466.15%41.43K-149.01%-230.48K76.43%99.93K139.82%155.72K174.87%16.25K-97.82%7.32K13.28%-92.56K-61.94%56.64K
-Change in other working capital -241.75%-2.93K-724.87%-61.52K6,636.17%341.73K14,401.95%352.26K-149.57%-5.14K219.76%2.07K-573.71%-7.46K-70.54%5.07K-1,871.94%-2.46K104.19%10.37K
Cash from discontinued investing activities
Operating cash flow 288.22%11.47K88.35%-1.23K-293.29%-16.89K123.26%2.63K54.79%-2.83K-125.08%-6.09K4.21%-10.59K96.31%-4.29K87.60%-11.28K-129.79%-6.26K
Investing cash flow
Cash flow from continuing investing activities 046.09%-3.01K
Net PPE purchase and sale ----------0----------------46.09%-3.01K--------
Cash from discontinued investing activities
Investing cash flow ----------0----------------46.09%-3.01K--------
Financing cash flow
Cash flow from continuing financing activities -137.40%-9.3K36.20%-11.19K-117.14%-4.5K-129.33%-4.11K-163.11%-7.73K24.88K-17.54K31.35%26.27K14.03K12.24K
Net issuance payments of debt -137.40%-9.3K36.20%-11.19K-117.14%-4.5K-129.33%-4.11K-163.11%-7.73K--24.88K---17.54K31.35%26.27K--14.03K--12.24K
Cash from discontinued financing activities
Financing cash flow -137.40%-9.3K36.20%-11.19K-117.14%-4.5K-129.33%-4.11K-163.11%-7.73K--24.88K---17.54K31.35%26.27K--14.03K--12.24K
Net cash flow
Beginning cash position -48.55%6.02K-53.69%18.45K90.91%39.84K-50.28%19.94K-10.61%30.49K19.32%11.71K90.91%39.84K-82.99%20.87K-65.86%40.1K-64.64%34.11K
Current changes in cash -88.47%2.17K55.84%-12.42K-212.76%-21.39K-468.32%-1.49K-276.27%-10.56K-22.70%18.78K-154.44%-28.13K118.64%18.97K99.73%-262-71.48%5.99K
End cash Position -73.14%8.19K-48.55%6.02K-53.69%18.45K-53.69%18.45K-50.28%19.94K-10.61%30.49K19.32%11.71K90.91%39.84K90.91%39.84K-65.86%40.1K
Free cash from 288.22%11.47K88.35%-1.23K-131.37%-16.89K118.37%2.63K54.79%-2.83K-125.08%-6.09K4.21%-10.59K94.01%-7.3K85.21%-14.29K-129.79%-6.26K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg